Literature DB >> 5063201

Modified hemagglutination-inhibition test for rubella employing human group O erythrocytes.

N J Schmidt, J Dennis.   

Abstract

A hemagglutination-inhibition (HI) test for rubella is described which utilizes human group O, rather than 1-day-old chick, erythrocytes. The test was found to be as sensitive and reproducible for detection of rubella antibody as HI tests employing chick erythrocytes. Advantages to the use of human erythrocytes are (i) they are more available, (ii) it is unnecessary to absorb natural agglutinins from human test sera, and (iii) heparin-MnCl(2)-treated sera do not agglutinate human erythrocytes, as is sometimes the case with chick erythrocytes. Factors influencing the reliability of the test are discussed.

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 5063201      PMCID： PMC380372          DOI： 10.1128/am.23.3.471-475.1972

Source DB:  PubMed          Journal:  Appl Microbiol        ISSN： 0003-6919


  17 in total

1.  A comparison of the haemagglutination-inhibition test and the neutralisation test for the detection of rubella antibody.

Authors:  A M Field; E M Vandervelde; K M Thompson; D N Hutchinson
Journal:  Lancet       Date:  1967-07-22       Impact factor: 79.321

2.  Evaluation of serological techniques for titration of rubella antibody.

Authors:  K L Herrmann; P E Halonen; J A Stewart; H L Casey; J M Ryan; A D Hall; K E Caswell
Journal:  Am J Public Health Nations Health       Date:  1969-02

3.  Serology of rubella. Virus neutralization, immunofluorescence in BHK21 cells, and hemagglutination inhibition.

Authors:  R Deibel; S M Cohen; C P Ducharme
Journal:  N Y State J Med       Date:  1968-06-01

4.  The hemagglutination inhibition test for rubella: a comparison of its sensitivity to that of neutralization, complement fixation and fluorescent antibody tests for diagnosis of infection and determination of immunity status.

Authors:  E H Lennette; N J Schmidt; R L Magoffin
Journal:  J Immunol       Date:  1967-10       Impact factor: 5.422

5.  Clinical studies with experimental live rubella virus vaccine (strain HPV-77). Evaluation of vaccine-induced immunity.

Authors:  H M Meyer; P D Parkman; T E Hobbins; F A Ennis
Journal:  Am J Dis Child       Date:  1968-06

6.  Attenuated rubella viruses. Laboratory and clinical characteristics.

Authors:  H M Meyer; P D Parkman; T E Hobbins; H E Larson; W J Davis; J P Simsarian; H E Hopps
Journal:  Am J Dis Child       Date:  1969-08

7.  Rubella vaccine trials in adults and children. Comparison of three attenuated vaccines.

Authors:  J A Dudgeon; W C Marshall; C S Peckham
Journal:  Am J Dis Child       Date:  1969-08

8.  Experience with a modified rubella hemagglutination inhibition antibody test.

Authors:  L Z Cooper; B Matters; J K Rosenblum; S Krugman
Journal:  JAMA       Date:  1969-01-06       Impact factor: 56.272

9.  Rubella hemagglutinin prepared with alkaline extraction of virus grown in suspension culture of BHK-21 cells.

Authors:  P E Halonen; J M Ryan; J A Stewart
Journal:  Proc Soc Exp Biol Med       Date:  1967-05

10.  Clinical and laboratory studies with rubella vaccines in adults.

Authors:  J A Dudgeon; W C Marshall; C S Peckham; G T Hawkins
Journal:  Br Med J       Date:  1969-02-01
View more
  8 in total

1.  Seroprevalence of rubella among women of childbearing age in Switzerland.

Authors:  J Zufferey; P Jacquier; S Chappuis; O Spinnler; P Hohlfeld; P L Zuber; J Bille
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-08       Impact factor: 3.267

2.  Rubella hemagglutination-inhibition test: false-positive reactions in sera contaminated with bacteria.

Authors:  J B Campbell; M Romach; M L Ellins
Journal:  J Clin Microbiol       Date:  1976-11       Impact factor: 5.948

3.  Rubella virus hemagglutination with human and animal erythrocytes: effect of age and trypsinization.

Authors:  A N Ponzi; A Pugliese; P Pertusio
Journal:  J Clin Microbiol       Date:  1978-05       Impact factor: 5.948

4.  Detection of rubella-specific immunoglobulin G: comparison of the enzyme-linked immunosorbent assay and an automated microparticle enzyme immunoassay (IMx).

Authors:  I J Skurrie; J L Head; S M Garland
Journal:  J Clin Microbiol       Date:  1991-08       Impact factor: 5.948

5.  Use of trypsin-modified human erythrocytes in rubella hemagglutination-inhibition testing.

Authors:  E P Quirin; D B Nelson; S L Inhorn
Journal:  Appl Microbiol       Date:  1972-09

6.  Enzyme-linked immunosorbent assay for rubella immunoglobulin G: new method for attachment of antigens to microtiter plates.

Authors:  I J Skurrie; G L Gilbert
Journal:  J Clin Microbiol       Date:  1983-05       Impact factor: 5.948

7.  Compatibility of trypsin-modified human erythrocytes in the rubella hemagglutination-inhibition test employing three serum treatment procedures.

Authors:  D B Nelson; P Quirin; S L Inhorn
Journal:  Appl Microbiol       Date:  1974-04

8.  Subclass distribution of rubella virus-specific immunoglobulin G.

Authors:  G A Linde
Journal:  J Clin Microbiol       Date:  1985-01       Impact factor: 5.948
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.